Results from new 2-year study shows the agent also improved cardiometabolic risk factors even more than the amount of weight loss would have predicted.

The investigational diet drug Acomplia (rimonabant) has staying power for weight loss and slimmer waists, and can improve lipids, but half of the participants dropped out of the study before the 2-year study was completed.

Unprocessed cocoa reduces the risks of cancer and cardiovascular disease, according to a study by Harvard Medical School.

Two major medical associations have joined forces in issuing recommendations intended to improve blood glucose management in hospitalized patients.

Study concluded that CSII was feasible and safe in preschool children and pump therapy reduced glycemic excursions.

Canadian Diabetes Association and Society for Diabetic Rights welcome new supplier. Hopefully it will also be made available in the U.S.

Gum disease in diabetic children may start as early as age six, according to a case-control study.

Those at highest risk for cardiovascular disease, generally have the lowest level of control of their high cholesterol levels.

JANUVIA (sitagliptin phosphate)is an investigational once-daily medicine with a novel mechanism of action for the treatment of type 2 diabetes. If approved, JANUVIA would potentially be the first in a new class of oral medications (DPP-4 inhibitors) that enhances the body’s own ability to lower blood sugar when it is …

A laser technique that uses ultraviolet energy to restore blood flow to blocked arteries may help people with advanced diabetes avoid one of the most devastating complications of the disease — amputation.